Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Learn about retirement plans that might be better than a 401k. Enhance your retirement strategy with informed choices.
27,827 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Oil prices fall, stock futures rise as reports of a U.S.-backed cease-fire plan with Iran surface, setting up a cauti...
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
The hyperliquid policy center argues that onchain perpetual futures can improve market transparency and efficiency, e...
NVIDIA stock sits at a crossroads as AI-driven demand and hyperscale spending shape a potential move toward $300. Ana...
Chevron stock climbs as crude prices rise, stoking debate on how high it can go this year. Analysts point to Hess syn...
Savers weigh where to park cash as rates shift. High yield savings accounts offer liquidity and FDIC protection with ...
A pipeline powerhouse with a 6% payout has drawn fresh attention as inflation-linked cash flows and fixed-fee contrac...
Gas lines, higher prices, and tighter budgets define daily life as Russia’s fuel crisis unfolds across regions. This ...
Supreme Court justices testified before a House panel seeking more security funding as threats against them grow. Bar...
Investors are watching Nextdoor's 2025 earnings closely as the Q4 results shed light on monetization of local communi...
A federal appeals court rejects the DOJ's bid to delay the tariff refund program, speeding relief for millions of tax...